Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

282
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
282
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

863
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
863
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

476
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
476
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

529
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
529
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

795
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
795
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

4.6K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Accurate prediction of intradialytic hypo- and hypertension in haemodialysis patients: the dual-attention Transformer model.

Clinical kidney journal·2026
Same author

Problematic relevance of animal studies on peritoneal vascularization to the clinical practice of peritoneal dialysis.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same author

IL-15 Links Muscle-Kidney Crosstalk to Preserving Podocyte Mitochondrial Fusion and Attenuating Diabetic Nephropathy.

Journal of cachexia, sarcopenia and muscle·2026
Same author

Mesenchymal Stem Cell-Derived Extracellular Vesicles Modulate the Course of Peritoneal Inflammation Through Metabolic and Epigenetic Regulation.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

Targeting STING to disrupt macrophage-mediated adhesion in encapsulating peritoneal sclerosis.

Communications biology·2025
Same author

Identifying New Risk Associations Between Chronic Physical Illness and Mental Health Disorders in China: Machine Learning Approach to a Retrospective Population Analysis.

JMIR AI·2025
Same journal

Brain Iron in Nucleus Accumbens and Cognitive Function in Preeclampsia.

Hypertension (Dallas, Tex. : 1979)·2026
Same journal

Hypertension Treatment Intentions: A Health Belief Model Analysis.

Hypertension (Dallas, Tex. : 1979)·2026
Same journal

Changes in Retinal Microvasculature During Healthy Pregnancy Measured by AO.

Hypertension (Dallas, Tex. : 1979)·2026
Same journal

Longitudinal Maternal IgG and IgA Glycosylation Profiles in Pregnancy Reveal Early Immune Alterations in Placenta-Related Complications: The Rotterdam Periconception Cohort.

Hypertension (Dallas, Tex. : 1979)·2026
Same journal

Blood Pressure Variability and Outcomes Across Antihypertensive Regimens.

Hypertension (Dallas, Tex. : 1979)·2026
Same journal

Rural Health and Health Disparities in Hypertension Management: A Scientific Statement From the American Heart Association.

Hypertension (Dallas, Tex. : 1979)·2026
See all related articles

Related Experiment Video

Updated: Feb 28, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

24.5K

Predicting Nocturnal Hypertension in CKD Through Table-Value Diffusion Model.

Xiaoyu Cai1, Rui Li2, Zhao Liu1

  • 1Division of Nephrology, Department of Medicine, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, China (X.C., Z.L., X.J., S.G., C.W.).

Hypertension (Dallas, Tex. : 1979)
|February 26, 2026
PubMed
Summary
This summary is machine-generated.

A new 7-variable diffusion model accurately predicts nocturnal hypertension (NH) in chronic kidney disease patients. This tool aids in targeted ambulatory blood pressure monitoring, improving screening efficiency for high-risk individuals.

Keywords:
blood pressure monitoring, ambulatorydeep learninghypertensionmachine learningpredictive learning modelsrenal insufficiency, chronic

More Related Videos

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.9K
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

781

Related Experiment Videos

Last Updated: Feb 28, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

24.5K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.9K
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

781

Area of Science:

  • Nephrology
  • Cardiology
  • Medical Informatics

Background:

  • Ambulatory blood pressure monitoring (ABPM) is crucial for diagnosing nocturnal hypertension (NH) in chronic kidney disease (CKD) patients.
  • Current ABPM methods are costly and time-consuming, necessitating efficient screening tools for high-risk NH.
  • Predictive models for NH are urgently needed to optimize patient management in CKD.

Purpose of the Study:

  • To develop and validate a predictive model for identifying patients with nocturnal hypertension (NH) among those with nondialysis chronic kidney disease (CKD).
  • To assess the efficacy of a novel table-value diffusion model in predicting NH risk.
  • To establish a risk stratification system for targeted ABPM screening in CKD.

Main Methods:

  • A large cohort of 5769 nondialysis CKD patients was analyzed, with data split into training, internal, and external test sets.
  • A table-value diffusion model was developed to predict NH probability using 7 core clinical variables.
  • Model performance was evaluated using area under the curve (AUC) and Cohen kappa index, with secondary validation on 1006 patients.

Main Results:

  • The 7-variable diffusion model demonstrated superior predictive performance compared to a logistic model in both internal (AUC 0.870 vs. 0.807) and external (AUC 0.854 vs. 0.792) test sets.
  • The model showed stability in secondary validation (AUC=0.869, Cohen kappa=0.560).
  • Risk stratification identified high-risk patients (>0.692) with a significantly higher incidence of adverse renal/cardiovascular events.

Conclusions:

  • A concise 7-variable diffusion model was successfully developed for predicting NH in CKD patients.
  • This diffusion model supports targeted ABPM screening, enhancing diagnostic efficiency.
  • The model facilitates risk stratification, enabling focused monitoring for adverse outcomes in high-risk CKD individuals.